LLY

Eli Lilly and Company

78
Fundamentals85/ 100
Valuation62/ 100
Upside potential72/ 100
Risk potential15/ 100

LLY has the edge over PARK overall, supported by stronger fundamentals and lower modeled downside.

PARK

Park Dental Partners, Inc. Common Stock

56
Fundamentals54/ 100
Valuation50/ 100
Upside potential59/ 100
Risk potential29/ 100

PARK's outlook is improving, though it still trails on the overall score.

LLY Fundamentals

MetricStatus
Healthy
Strong
Strong
Healthy

LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.

PARK Fundamentals

MetricStatus
Stable
Under pressure
Under pressure
Strong

PARK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.

LLY PE Valuation

CHEAPFAIREXPENSIVE37x74x111x147x
CHEAPFAIREXPENSIVE37x74x111x147x
LevelPEPriceVs current
Cheap27x$845-41%
Forward30x$1,427—
Current46x$1,427—
Fair48x$1,466+2.7%
Expensive85x$2,612+83%

Historical ranges are pointers, not guarantees.

LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.

PARK PE Valuation

PARK has no meaningful PE right now: it lost money over the past year.

LLY Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for LLY, with profitability improving.

PARK Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
High

Analysts expect earnings and revenue growth for PARK, with profitability improving.

LLY Risk to reward

ScenarioChangePrice
Upside+39%$1,988.49
Downside-15%$1,209.08

Calculated from the latest close: $1,427.28 on Nov 12.

LLY has a better modeled risk to reward balance than PARK, with more potential upside relative to its potential downside.

PARK Risk to reward

ScenarioChangePrice
Upside+41%$29.93
Downside-29%$15.09

Calculated from the latest close: $21.19 on Nov 12.

PARK trails LLY on modeled risk to reward, with less potential upside relative to its potential downside.

LLY Earnings Per Share

Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
QuarterTTM EPSYoY
Forward$46.82+52%
Q3 2026$30.81+51%
Q2 2026$29.80+95%
Q1 2026$28.15+129%
Q4 2025$22.95+96%
Q3 2025$20.44+121%
Q2 2025$15.30+88%
Q1 2025$12.29+81%
Q4 2024$11.71+102%

LLY has the edge over PARK on earnings quality, reporting a profit while its opponent remains loss making.

PARK Earnings Per Share

Q4 2024: $2.41Q1 2025: $1.57Q2 2025: $0.97Q3 2025: $1.23Q4 2025: $-0.06Q1 2026: $-0.52Q2 2026: $-0.91Q3 2026: $-0.95Forward: $1.42
Q4 2024: $2.41Q1 2025: $1.57Q2 2025: $0.97Q3 2025: $1.23Q4 2025: $-0.06Q1 2026: $-0.52Q2 2026: $-0.91Q3 2026: $-0.95Forward: $1.42
QuarterTTM EPSYoY
Forward$1.42—
Q3 2026-$0.95-177%
Q2 2026-$0.91-194%
Q1 2026-$0.52-133%
Q4 2025-$0.06-102%

PARK has swung to a loss: it lost $0.95 per share over the past year, after a profit the year before.

LLY Quarterly Revenue

Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
QuarterRevenueYoY
Q3 2026$24.4B+39%
Q2 2026$23B+48%
Q1 2026$19.8B+56%
Q4 2025$19.3B+43%
Q3 2025$17.6B+54%
Q2 2025$15.6B+38%
Q1 2025$12.7B+45%
Q4 2024$13.5B+45%

LLY has the edge over PARK on sales, with stronger typical year-over-year growth.

PARK Quarterly Revenue

Q1 2024: $59MQ2 2024: $59MQ3 2024: $55MQ4 2024: $57MQ1 2025: $61MQ2 2025: $61MQ3 2025: $61MQ4 2025: $61MQ1 2026: $63MQ2 2026: $66MQ3 2026: $65M
Q1 2024: $59MQ2 2024: $59MQ3 2024: $55MQ4 2024: $57MQ1 2025: $61MQ2 2025: $61MQ3 2025: $61MQ4 2025: $61MQ1 2026: $63MQ2 2026: $66MQ3 2026: $65M
QuarterRevenueYoY
Q3 2026$64.9M+6%
Q2 2026$66.2M+8.5%
Q1 2026$62.7M+2.7%
Q4 2025$61.2M+7.5%
Q3 2025$61.3M+11%
Q2 2025$61M+3.8%
Q1 2025$61M+3.8%

PARK's revenue has grown year over year every quarter since early 2025: $65M last quarter, up 6% from the same quarter a year ago.

LLY Free Cash Flow

Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
QuarterFree cash flowYoY
Q3 2026$8.2B+22%
Q2 2026$7.8B+458%
Q1 2026$3B+1826%
Q4 2025$677.9M-31%
Q3 2025$6.7B+186%
Q2 2025$1.4B+476%
Q1 2025$156.1M-13%
Q4 2024$977.8M+$2.4B

LLY has the edge over PARK on cash flow, with more consistent year-over-year improvement.

PARK Free Cash Flow

Q1 2024: $1MQ2 2024: $1MQ3 2024: $6MQ4 2024: $2MQ1 2025: $3MQ2 2025: $2MQ3 2025: $6MQ4 2025: −$491,000Q1 2026: $3MQ2 2026: $2MQ3 2026: −$569,000
Q1 2024: $1MQ2 2024: $1MQ3 2024: $6MQ4 2024: $2MQ1 2025: $3MQ2 2025: $2MQ3 2025: $6MQ4 2025: −$491,000Q1 2026: $3MQ2 2026: $2MQ3 2026: −$569,000
QuarterFree cash flowYoY
Q3 2026-$569K-110%
Q2 2026$2.2M+26%
Q1 2026$2.7M-21%
Q4 2025-$491K-123%
Q3 2025$5.6M-5.6%
Q2 2025$1.8M+53%
Q1 2025$3.4M+196%

PARK usually generates cash, though not every quarter: the latest was −$569,000, but it generated $4M over the past year.

LLY Total Shares

Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
PeriodChange %Net change
Quarterly0%-300K shares
1 year-0.6%-5.4M shares
3 years-0.7%-6.4M shares
5 years-1.9%-17.4M shares
Available history-4.5%-42.3M shares

LLY has the edge over PARK on shareholder dilution, with a more favorable share count trend.

PARK Total Shares

Q1 2024: 2MQ2 2024: 2MQ3 2024: 4MQ4 2024: 4MQ1 2025: 4MQ2 2025: 4MQ3 2025: 4MQ4 2025: 4MQ1 2026: 4MQ2 2026: 6MQ3 2026: 6M
Q1 2024: 2MQ2 2024: 2MQ3 2024: 4MQ4 2024: 4MQ1 2025: 4MQ2 2025: 4MQ3 2025: 4MQ4 2025: 4MQ1 2026: 4MQ2 2026: 6MQ3 2026: 6M
PeriodChange %Net change
Quarterly+2%+126K shares
1 year+55%+2.3M shares

PARK has 6M diluted shares, up 55% from a year ago.

LLY Net Leverage

Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
QuarterNet LeverageStatus
Q3 20261.2xHealthy
Q2 20261.3xHealthy
Q1 20261.2xHealthy
Q4 20251.3xHealthy
Q3 20251.3xHealthy
Q2 20252.0xHealthy
Q1 20252.3xModerate
Q4 20242.1xModerate

LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.

PARK Net Leverage

Q1 2025: 3.2xQ2 2025: 3.1xQ3 2025: 2.6xQ4 2025: -2,580.6xQ1 2026: -2.8xQ2 2026: -27.0x
Q1 2025: 3.2xQ2 2025: 3.1xQ3 2025: 2.6xQ4 2025: -2,580.6xQ1 2026: -2.8xQ2 2026: -27.0x
QuarterNet LeverageStatus
Q2 2026-27.0xNet Cash
Q1 2026-2.8xNet Cash
Q4 2025-2,580.6xNet Cash
Q3 20252.6xModerate
Q2 20253.1xElevated
Q1 20253.2xElevated

PARK has the edge over LLY on leverage, with a lower net debt burden relative to earnings.

LLY Weekly Momentum

MetricValueStatus
RSI68.3Neutral
Stochastic84.1Overbought

LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).

PARK Weekly Momentum

MetricValueStatus
RSI57.6Neutral
Stochastic32.0Neutral

PARK's weekly RSI is 58 (neutral) and its Stochastic is 32 (neutral).

LLY PE vs Healthcare Sector

MetricLLYSector medianRelative
PE46x26x79% above
PE %482919 pts above

LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.

PARK PE vs Healthcare Sector

PARK has no meaningful PE right now: it lost money over the past year.

LLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1,279.412% above
20 week MA$1,218.817% above
50 week MA$1,102.229% above
100 week MA$954.150% above
200 week MA$797.579% above

PARK has stronger trend alignment. LLY is above 5 of 5 weekly averages versus PARK above 3 of 3.

PARK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$20.15.3% above
20 week MA$20.34.4% above
50 week MA$18.515% above

PARK is in an uptrend: it's above all three of its weekly moving averages, and 15% above its 50-week average.

LLY Yearly ROI

YearStart priceEnd priceROI
2020$131.5$166.7+27%
2021$166.7$273.1+64%
2022$273.1$367.9+35%
2023$367.9$582.9+58%
2024$582.9$783.2+34%
2025$783.2$1,077.8+38%
2026 YTD$1,077.8$1,427.3+32%

LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.

PARK Yearly ROI

YearStart priceEnd priceROI
2025$13.3$14.7+10%
2026 YTD$14.7$21.2+44%

PARK has the edge over LLY on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key